NSCLC, METASTATIC 1

Cisplatin plus pemetrexed (CP) versus cisplatin plus gemcitabine (CG) according to thymidylate synthase expression in non-squamous NSCLC: A biomarker-stratified randomized phase II trial

M. Ahn